AlanFSchatzbergMD
Psychiatry • Stanford, CADirector, Stanford Mood Disorders Center. Professor, Department of Psychiatry and Behavioral Sciences Stanford University Medical Center.
Dr. Schatzberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-498-5710Fax+1 650-498-5294
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1969 - 1972
Lenox Hill Hospital-Northwell HealthInternship, Transitional Year, 1968 - 1969
New York University School of MedicineClass of 1968
Certifications & Licensure
CA State Medical License 1974 - 2026
MA State Medical License 1969 - 2025- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Women's Health Castle Connolly, 2008
- Elected Member Institute of Medicine, 2003
- Join now to see all
Clinical Trials
- Age-Related Changes in Stress Hormone Regulation Start of enrollment: 2000 Dec 01
- Clinical and Biological Characteristics of Psychotic Depression Start of enrollment: 2005 Aug 01
- Genetics of Symptomatology and Treatment Response in Psychotic Major Depression Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine Trial.Theresa R Lii, Josephine R Flohr, Robin L Okada, Lisa J Cianfichi, Laura M Hack
Medrxiv. 2024-11-02 - Advancements, challenges and future horizons in personalized psychiatry.Giampaolo Perna, Daniela Caldirola, Alan F Schatzberg, Charles B Nemeroff
World Psychiatry. 2024-10-01 - Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine for Major Depressive Disorder: Findings From Placebo-Controlled Trials.Joshua T Jordan, Li Shen, Nicholas J Cooper, Samantha V Goncalves, Madhukar H Trivedi
The Journal of Clinical Psychiatry. 2024-09-04
Journal Articles
- Splice-Break: Exploiting an RNA-Seq Splice Junction Algorithm to Discover Mitochondrial DNA Deletion Breakpoints and Analyses of Psychiatric DisordersFrancis S Lee, Alan F Schatzberg, Jack D Barchas, Virginia Kimonis, Elizabeth C Chao, Nucleic Acids Research
- Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature
- American Psychiatric Association PublishingAlan Schatzberg, MD, National Institutes of Health
Press Mentions
Terence Ketter Dies at 74December 20th, 2024- Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe DepressionSeptember 6th, 2022
- A Virtual Conversation with with Dr. Amit Etkin, Founder and CEO of Alto NeuroscienceMarch 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
